tiprankstipranks
Trending News
More News >
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market

Lepu Biopharma Co. Ltd. Class H (2157) Income Statement

Compare
3 Followers

Lepu Biopharma Co. Ltd. Class H Income Statement

Last quarter (Q2 2025), Lepu Biopharma Co. Ltd. Class H's total revenue was ¥465.94M, an increase of 203.29% from the same quarter last year. In Q2, Lepu Biopharma Co. Ltd. Class H's net income was ¥41.74M. See Lepu Biopharma Co. Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 367.79M¥ 225.35M¥ 15.57M¥ 0.00¥ 0.00
Gross Profit
¥ 292.97M¥ 197.07M¥ 13.57M¥ 0.00¥ 0.00
Operating Expenses
¥ 683.74M¥ 192.28M¥ 718.05M¥ 1.01B¥ 520.35M
Depreciation and Amortization
¥ 83.91M¥ 102.57M¥ 95.45M¥ 77.18M¥ 63.69M
EBITDA
¥ -311.94M¥ 86.95M¥ -596.53M¥ -865.23M¥ -383.76M
Operating Income
¥ -390.76M¥ 4.80M¥ -704.48M¥ -1.01B¥ -520.35M
Other Income/Expenses
¥ -33.43M¥ -35.10M¥ 5.04M¥ -19.23M¥ -93.10M
Pretax Income
¥ -424.19M¥ -30.30M¥ -699.44M¥ -1.03B¥ -613.45M
Net Income
¥ -411.38M¥ -22.10M¥ -689.05M¥ -1.01B¥ -581.85M
Per Share Metrics
Basic EPS
¥ -0.24¥ -0.01¥ -0.42¥ -0.61¥ -0.35
Diluted EPS
¥ -0.24¥ -0.01¥ -0.42¥ -0.61¥ -0.35
Weighted Average Shares Outstanding
1.69B 1.66B 1.64B 1.66B 1.66B
Weighted Average Shares Outstanding (Diluted)
1.69B 1.66B 1.64B 1.66B 1.66B
Currency in CNY

Lepu Biopharma Co. Ltd. Class H Earnings and Revenue History